Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: Implications for therapy

Gastroenterology

Volumn 118, Issue 6, 2000, Pages 1261-1265

  Rockey, Don C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASOACTIVE AGENT;

DRUG BINDING; DRUG POTENCY; DRUG SPECIFICITY; EDITORIAL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER FIBROSIS; LIVER PROTECTION; PORTAL HYPERTENSION; PRIORITY JOURNAL; STELLATE CELL;

EID: 0034116973     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(00)70379-9     Document Type: Editorial

References (30)

1. SL Friedman FJ Roll J Boyles DM Bissell Hepatic lipocytes: the principal collagen-producing cells of normal rat liver Proc Natl Acad Sci U S A 82 1985 8681 8685
2. DC Rockey JK Boyles G Gabbiani SL Friedman Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture J Submicrosc Cytol Pathol 24 1992 193 203
3. M Yanagisawa H Kurihara S Kimura A novel potent vasoconstrictor peptide produced by vascular endothelial cells [see comments] Nature 332 1988 411 415
4. H Arai S Hori I Aramori H Ohkubo S Nakanishi Cloning and expression of a cDNA encoding an endothelin receptor [see comments] Nature 348 1990 730 732
5. T Sakurai M Yanagisawa Y Takuwa Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor [see comments] Nature 348 1990 732 735
6. DP Brooks DK Jorkasky MI Freed EH Ohlstein Pathophysiological role of endothelin and potential therapeutic targets for receptor antagonists Endothelin: molecular biology, physiology, and pathology 1998 Humana Totowa, New Jersey 223 268
7. AP Giaid M Yanagisawa D Langleben Expression of endothelin-1 in the lungs of patients with pulmonary hypertension N Engl J Med 328 1993 1732 1739
8. RD Forbes P Cernacek S Zheng M Gomersall RD Guttmann Increased endothelin expression in a rat cardiac allograft model of chronic vascular rejection Transplantation 61 1996 791 797
9. S Morelli C Ferri E Polettini Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis [see comments] Am J Med 99 1995 255 260
10. DE Kohan Endothelins in the normal and diseased kidney Am J Kidney Dis 29 1997 2 26
11. M Pinzani S Milani R De Franco C Grappone A Caligiuri A Gentilini C Tosti-Guerra M Maggi P Failli C Ruocco P Gentilini Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells Gastroenterology 110 1996 534 548
12. R Shao W Yan DC Rockey Regulation of endothelin-1 synthesis by endothelin-converting enzyme-1 during wound healing J Biol Chem 274 1999 3228 3234
13. DC Rockey JJ Chung Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension Gastroenterology 114 1998 344 351
14. V Shah M Toruner F Haddad G Cadelina A Papapetropoulos K Choo WC Sessa RJ Grozman Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat Gastroenterology 117 1999 1222 1228
15. R Bataller P Ginès JM Nicolás MN Görbig E Garcia-Ramallo X Gasull J Bosch V Arroyo J. Rodés Angiotensin II induces contraction and proliferation of human hepatic stellate cells Gastroenterology 118 2000 1149 1156
16. F Ballet Y Chretien C Rey R Poupon Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver J Pharmacol Exp Ther 244 1988 283 289
17. AW Schneider JF Kalk CP Klein Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis Hepatology 29 1999 334 339
18. KT Weber Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair Semin Nephrol 17 1997 467 491
19. KH Yoo BA Thornhill JT Wolstenholme RL Chevalier Tissue-specific regulation of growth factors and clusterin by angiotensin II Am J Hypertens 11 1998 715 722
20. MR Weir VJ Dzau The renin-angiotensin-aldosterone system: a specific target for hypertension management Am J Hypertens 12 1999 205S 213S
21. J-J Cho B Hocher H Herbst J-D Jia M Ruehl EG Hahn EO Riecken D Schuppan An oral endothelin A-receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis Gastroenterology 118 2000 1169 1178
22. K Gondo T Ueno M Sakamoto S Sakisaka M Sata K Tanikawa The endothelin-1 binding site in rat liver tissue: light- and electron-microscopic autoradiographic studies Gastroenterology 104 1993 1745 1749
23. C Housset DC Rockey DM Bissell Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1 Proc Natl Acad Sci U S A 90 1993 9266 9270
24. TF Luscher RR Wenzel Endothelin and endothelin antagonists: pharmacology and clinical implications Agents Actions Suppl 45 1995 237 253
25. CR Gandhi EM Nemoto SC Watkins VM Subbotin An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats Liver 18 1998 39 48
26. DC Rockey JJ Chung Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing J Clin Invest 98 1996 1381 1388
27. J Reichen AL Gerbes MJ Steiner H Sagesser M Clozel The effect of endothelin and its antagonist bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver J Hepatol 28 1998 1020 1030
28. B receptor antagonist, in portal hypertensive rats Hepatology 28 1998 655 659
29. PS Kamath GM Tyce VM Miller BS Edwards DK Rorie Endothel-in-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension Hepatology 30 1999 401 407
30. M Bauer I Bauer NV Sonin N Kresge R Baveja Y Yokoyama D Harding JX Zhang MG Clemens Functional significance of endothelin B receptors in mediating sinusoidal and extrasinusoidal effects of endothelins in the intact rat liver Hepatology 31 2000 937 947